MedPath

The effects of sleep deprivation and dexamphetamine on driving, neuropsychological function and brain activity in professional drivers

Phase 1
Completed
Conditions
Sleep deprivation
Neurological - Other neurological disorders
Registration Number
ACTRN12605000730606
Lead Sponsor
IBAS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
40
Inclusion Criteria

(Control group): Curent drivers license. Not used amphetamine within last 10 years. (Users group): Current drivers license. Currently use amphetamine.

Exclusion Criteria

History of cardiovascular disease, hypertension, epilepsy, diabetes, psychiatric illness; heavy Smokers; 5 or more caffienated beverages per day; Visual impairment that does not correct with glasses; English not first language.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath